Literature DB >> 8387299

Effects of thrombin receptor activating peptide on phosphoinositide hydrolysis and protein kinase C activation in cultured rat aortic smooth muscle cells: evidence for "tethered-ligand" activation of smooth muscle cell thrombin receptors.

M L Webb1, D S Taylor, C J Molloy.   

Abstract

Phosphoinositide hydrolysis and protein kinase C (PKC) activation were examined in response to treatment of rat aortic smooth muscle cells with alpha-thrombin and a seven amino acid thrombin receptor activating peptide (TRAP-7; SFLLRNP). alpha-Thrombin and TRAP-7 stimulated total inositol phosphate (IP) accumulation and phosphorylation of a specific endogenous substrate for activated PKC. Acetylated TRAP-7 and "reverse" TRAP (FSLLRNPNDKYEPF) were ineffective in stimulating signal transduction. The active site inhibitor, MD805 (argatroban), and the anion-binding exosite inhibitor, BMS 180,742, reduced the IP response to alpha-thrombin in a concentration-dependent manner. In contrast, the TRAP-7-induced IP response was not affected by either inhibitor. These data are consistent with the tethered-ligand hypothesis for thrombin receptor activation in rat aortic smooth muscle cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8387299     DOI: 10.1016/0006-2952(93)90297-a

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  2 in total

1.  Thrombin receptor activation elicits rapid protein tyrosine phosphorylation and stimulation of the raf-1/MAP kinase pathway preceding delayed mitogenesis in cultured rat aortic smooth muscle cells: evidence for an obligate autocrine mechanism promoting cell proliferation induced by G-protein-coupled receptor agonist.

Authors:  C J Molloy; J E Pawlowski; D S Taylor; C E Turner; H Weber; M Peluso
Journal:  J Clin Invest       Date:  1996-03-01       Impact factor: 14.808

2.  Raf-1 kinase regulates smooth muscle contraction in the rat mesenteric arteries.

Authors:  Kunju Sathishkumar; Uma Yallampalli; Rebekah Elkins; Chandra Yallampalli
Journal:  J Vasc Res       Date:  2010-01-27       Impact factor: 2.045

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.